<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2011-04-15 10:46:21Health Government Pharmaceuticals policy Medicare Medicaid United States Department of Health and Human Services United States National Health Care Act Office of Inspector General U.S. Department of Health and Human Services Daniel R. Levinson Healthcare reform in the United States Federal assistance in the United States Presidency of Lyndon B. Johnson |
Add to Reading List |
Base file for CMP Front Matter | March 4, 2013 Daniel R. Levinson Inspector General U.S. Department of Health and Human Services 330 Independence Avenue, SW Washington, DC 20201DocID: 1jTnA - View Document |
| Microsoft Word - PHARMARICADOC2.docDocID: 1abBi - View Document |
| UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES POLICIES AND PRINCIPLES FOR ASSURING SCIENTIFIC INTEGRITY Overview Purpose. This document describes Department of Health and Human Services (“Departmental” or “DocID: 1a2rp - View Document |
| Report on External Quality Control Review, U.S. Department of Health and Human Services, Office of Inspector GeneralDocID: 19TaC - View Document |
| FY 2015 Justification of Estimates for Appropriations CommitteesDocID: 19RaG - View Document |